Article metrics

Extended report
Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
Free

 

Online download statistics by month:

Online download statistics by month: August 2015 to April 2021

AbstractFullPdf
Aug 2015105784148
Sep 20151569134223
Oct 20153313457
Nov 2015882129
Dec 2015971619
Jan 20162107137295
Feb 2016116088166
Mar 20164046584
Apr 20163174250
May 20161734346
Jun 20161344745
Jul 20161275745
Aug 20161053839
Sep 2016905438
Oct 20161083936
Nov 2016885350
Dec 2016865441
Jan 2017815037
Feb 20172918028
Mar 2017286130
Apr 2017416133
May 201786739
Jun 2017305123
Jul 2017895828
Aug 2017804314
Sep 20171226521
Oct 20171268942
Nov 20171175831
Dec 2017945731
Jan 20181645317
Feb 20181245735
Mar 20181576338
Apr 20181656043
May 2018875720
Jun 2018703814
Jul 2018765113
Aug 20181084813
Sep 2018874717
Oct 20181154622
Nov 20181128829
Dec 201812410815
Jan 2019825335
Feb 2019584711
Mar 2019614720
Apr 2019755727
May 2019655831
Jun 2019514123
Jul 2019544232
Aug 2019321917
Sep 2019302918
Oct 2019513423
Nov 2019776239
Dec 2019403529
Jan 2020524930
Feb 202028027423
Mar 2020624027
Apr 2020715031
May 2020604827
Jun 2020494626
Jul 2020554713
Aug 2020424038
Sep 202016315024
Oct 2020484128
Nov 2020755523
Dec 2020595338
Jan 2021625020
Feb 2021695442
Mar 2021584525
Apr 2021484329
Total1220441712793